Edition:
India

Cambrex Corp (CBM.N)

CBM.N on New York Stock Exchange

50.45USD
24 Mar 2017
Change (% chg)

$-0.45 (-0.88%)
Prev Close
$50.90
Open
$51.00
Day's High
$51.00
Day's Low
$50.05
Volume
65,827
Avg. Vol
76,796
52-wk High
$62.50
52-wk Low
$38.35

CBM.N

Chart for CBM.N

About

Cambrex Corporation (Cambrex) is a life sciences company. It provides products and services for the development and commercialization of generic therapeutics. It operates through four segments, which are manufacturing facilities that have been aggregated as a single segment. Its manufacturing facilities are owned by the... (more)

Overall

Beta: 2.13
Market Cap(Mil.): $1,714.54
Shares Outstanding(Mil.): 33.98
Dividend: --
Yield (%): --

Financials

  CBM.N Industry Sector
P/E (TTM): 19.05 28.94 29.75
EPS (TTM): 2.65 -- --
ROI: 19.58 13.60 13.11
ROE: 24.38 14.50 14.26

BRIEF-Cambrex reports Q3 GAAP earnings per share $0.42 from continuing operations

* Says company expects full year 2016 sales, excluding impact of foreign currency, to increase between 12% and 14% compared to 2015.

04 Nov 2016

BRIEF-Cambrex Corp appoints Bernhard Hampl to the board of directors

* Bernhard Hampl appointed to the board of directors of Cambrex Corporation Source text for Eikon: Further company coverage:

31 Oct 2016

BRIEF-Cambrex to acquire Pharmacore to expand clinical stage API capabilities

* Cambrex to acquire Pharmacore Inc to expand clinical stage API capabilities

26 Sep 2016

More From Around the Web

Earnings vs. Estimates